185 related articles for article (PubMed ID: 30146185)
1. Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.
Hinkle JT; Perepezko K; Mills KA; Mari Z; Butala A; Dawson TM; Pantelyat A; Rosenthal LS; Pontone GM
Parkinsonism Relat Disord; 2018 Oct; 55():8-14. PubMed ID: 30146185
[TBL] [Abstract][Full Text] [Related]
2. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson's disease patients with impulse control disorders.
Navalpotro-Gomez I; Dacosta-Aguayo R; Molinet-Dronda F; Martin-Bastida A; Botas-Peñin A; Jimenez-Urbieta H; Delgado-Alvarado M; Gago B; Quiroga-Varela A; Rodriguez-Oroz MC
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2065-2076. PubMed ID: 31273436
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the availability of dopamine transporter and olfactory function in healthy subjects.
Pak K; Kim K; Lee MJ; Lee JM; Kim BS; Kim SJ; Kim IJ
Eur Radiol; 2018 Apr; 28(4):1756-1760. PubMed ID: 29164380
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson's Disease.
Muñoz-Delgado L; Labrador-Espinosa MÁ; Macías-García D; Jesús S; Benítez Zamora B; Fernández-Rodríguez P; Adarmes-Gómez AD; Reina Castillo MI; Castro-Labrador S; Silva-Rodríguez J; Carrillo F; García Solís D; Grothe MJ; Mir P
Mov Disord; 2023 May; 38(5):755-763. PubMed ID: 36912400
[TBL] [Abstract][Full Text] [Related]
5. Predicting Neuropsychiatric Symptoms of Parkinson's Disease with Measures of Striatal Dopaminergic Deficiency.
Bishnoi R; Badir MC; Surya S; Youssef NA
Curr Alzheimer Res; 2021; 18(6):499-504. PubMed ID: 34455969
[TBL] [Abstract][Full Text] [Related]
6. Current coffee consumption is associated with decreased striatal dopamine transporter availability in Parkinson's disease patients and healthy controls.
Wang C; Zhou C; Guo T; Jiaerken Y; Yang S; Xu X; Hu L; Huang P; Xu X; Zhang M
BMC Med; 2023 Jul; 21(1):272. PubMed ID: 37491235
[TBL] [Abstract][Full Text] [Related]
7. Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.
Chung SJ; Yoo HS; Oh JS; Kim JS; Ye BS; Sohn YH; Lee PH
Parkinsonism Relat Disord; 2018 Jun; 51():43-48. PubMed ID: 29526657
[TBL] [Abstract][Full Text] [Related]
8. Distinct dopaminergic abnormalities in traumatic brain injury and Parkinson's disease.
Jenkins PO; Roussakis AA; De Simoni S; Bourke N; Fleminger J; Cole J; Piccini P; Sharp D
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):631-637. PubMed ID: 32381639
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
[TBL] [Abstract][Full Text] [Related]
10. Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease.
Shin HW; Chung SJ; Lee S; Cha J; Sohn YH; Yun M; Lee PH
Clin Nucl Med; 2020 Aug; 45(8):e342-e348. PubMed ID: 32520498
[TBL] [Abstract][Full Text] [Related]
11. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
Liu R; Umbach DM; Tröster AI; Huang X; Chen H
Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
[TBL] [Abstract][Full Text] [Related]
12. Physical activity mediates the association between striatal dopamine transporter availability and cognition in Parkinson's disease.
Shih CH; Moore K; Browner N; Sklerov M; Dayan E
Parkinsonism Relat Disord; 2019 May; 62():68-72. PubMed ID: 30722964
[TBL] [Abstract][Full Text] [Related]
13. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
[TBL] [Abstract][Full Text] [Related]
14. Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients.
Erro R; Pappatà S; Amboni M; Vicidomini C; Longo K; Santangelo G; Picillo M; Vitale C; Moccia M; Giordano F; Brunetti A; Pellecchia MT; Salvatore M; Barone P
Parkinsonism Relat Disord; 2012 Nov; 18(9):1034-8. PubMed ID: 22789824
[TBL] [Abstract][Full Text] [Related]
15. Survival in Parkinson's disease in relation to striatal dopamine transporter binding.
Mäkinen E; Joutsa J; Vahlberg T; Kaasinen V
Parkinsonism Relat Disord; 2017 Sep; 42():66-72. PubMed ID: 28662820
[TBL] [Abstract][Full Text] [Related]
16. Striatal Dopamine Transporter Modulation After Rotigotine: Results From a Pilot Single-Photon Emission Computed Tomography Study in a Group of Early Stage Parkinson Disease Patients.
Rossi C; Genovesi D; Marzullo P; Giorgetti A; Filidei E; Corsini GU; Bonuccelli U; Ceravolo R
Clin Neuropharmacol; 2017; 40(1):34-36. PubMed ID: 27941527
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease.
Fiorenzato E; Antonini A; Bisiacchi P; Weis L; Biundo R
Mov Disord; 2021 Oct; 36(10):2303-2313. PubMed ID: 34124799
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.
Tinaz S; Chow C; Kuo PH; Krupinski EA; Blumenfeld H; Louis ED; Zubal G
Clin Nucl Med; 2018 Jan; 43(1):e1-e7. PubMed ID: 29112012
[TBL] [Abstract][Full Text] [Related]
19. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
[TBL] [Abstract][Full Text] [Related]
20. Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease.
Murtomäki K; Mertsalmi T; Jaakkola E; Mäkinen E; Levo R; Nojonen T; Eklund M; Nuuttila S; Lindholm K; Pekkonen E; Joutsa J; Noponen T; Ihalainen T; Kaasinen V; Scheperjans F
Mov Disord; 2022 Jun; 37(6):1284-1289. PubMed ID: 35274368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
